Gastrointestinal Cancer

Early-Onset, Severe Cardiac Toxicity Common in Locoregional Esophageal Cancer Treated with Radiotherapy

By

Susan Moench, PhD, PA-C

Publish Date July 15, 2020

Findings from a recent study support pretreatment screening for heart disease in patients with newly diagnosed, locoregional esophageal cancer.

Antidiabetic Medication Adherence, Survival for Patients With Diabetes and Colorectal Cancer

By

Susan Moench, PhD, PA-C

Publish Date June 22, 2020

Researchers assessed whether adherence to oral antidiabetic medication was a modifiable prognostic factor in patients with CRC and preexisting diabetes.

Opdivo Approved for Advanced Esophageal Squamous Cell Carcinoma

By

Brian Park, PharmD

Publish Date June 12, 2020

The FDA has approved Opdivo® (nivolumab; Bristol Myers Squibb) for the treatment of patients with unresectable advanced, recurrent or metastatic esophageal squamous cell carcinoma (ESCC) after prior fluoropyrimidine- and platinum-based chemotherapy.

Body Composition at Presentation Predicts Survival in Metastatic Esophageal Cancer

By

Susan Moench, PhD, PA-C

Publish Date June 8, 2020

In this study, skeletal muscle mass, as well as subcutaneous and visceral adiposity, were measured using CT imaging performed at baseline at the level of the L3 vertebrae.

Nutritional Index, ECOG Performance Status Indicative of Prognosis for Patients With Gastric And Esophageal Adenocarcinoma

By

Jessica Nye, PhD

Publish Date June 8, 2020

Early detection of malnourishment in patients with gastric and esophageal adenocarcinoma identified as a strategy for improving outcomes for these patients.